PDS Biotechnology Files 8-K

Ticker: PDSB · Form: 8-K · Filed: Mar 7, 2025 · CIK: 1472091

Pds Biotechnology Corp 8-K Filing Summary
FieldDetail
CompanyPds Biotechnology Corp (PDSB)
Form Type8-K
Filed DateMar 7, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, corporate-filing, financials

TL;DR

PDS Biotech filed an 8-K on 3/7/25, standard corporate update.

AI Summary

PDS Biotechnology Corporation filed an 8-K on March 7, 2025, reporting other events and financial statements. The company, formerly known as Edge Therapeutics, Inc., is incorporated in Delaware and headquartered in Princeton, NJ.

Why It Matters

This filing indicates routine corporate reporting and potential updates on financial status or significant events for PDS Biotechnology Corp.

Risk Assessment

Risk Level: low — This filing is a routine 8-K report and does not appear to contain significant new information that would immediately impact risk.

Key Players & Entities

  • PDS Biotechnology Corporation (company) — Registrant
  • Edge Therapeutics, Inc. (company) — Former Company Name
  • March 7, 2025 (date) — Date of Report
  • Princeton, NJ (location) — Principal Executive Offices

FAQ

What is the primary purpose of this 8-K filing for PDS Biotechnology Corporation?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of March 7, 2025.

When was PDS Biotechnology Corporation incorporated and where are its principal executive offices located?

PDS Biotechnology Corporation was incorporated in Delaware and its principal executive offices are located at 303A College Road East, Princeton, NJ 08540.

Does PDS Biotechnology Corporation have a former company name listed in this filing?

Yes, the former company name listed is Edge Therapeutics, Inc., with a date of name change on September 11, 2009.

What is the SIC code for PDS Biotechnology Corporation?

The Standard Industrial Classification (SIC) code for PDS Biotechnology Corporation is 2834, which corresponds to Pharmaceutical Preparations.

What is the SEC file number and film number associated with this filing?

The SEC file number is 001-37568 and the film number is 25717714.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 7, 2025 regarding PDS Biotechnology Corp (PDSB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.